South Africa Establishment Licence Renewal: Five-Year Cycle, Fees and ISO 13485

1. Key takeaways

The validity period of a South African medical device Establishment Licence is 5 years. Renewal is handled under Section 22D of the Medicines and Related Substances Act, with specific requirements set out in Notice 1515 Regulation 6 (validity and renewal of licences issued under Regulation 5). SAHPRA regulated renewal operations through its communication on the Medical Device Establishment Licence renewal process (MD06-2025/2026), published on 17 July 2025. Renewal and the annual retention fee are two independent obligations: renewal falls due every 5 years, while the annual retention fee is payable every year; even in a renewal year, the annual retention fee must still be paid.

Renewal is also where the ISO 13485 regime first bites: from 1 June 2025, renewal applications must be supported by a valid ISO 13485:2016 certificate issued by a SAHPRA-recognised CAB in the name of the South African licensed establishment and bearing the licensed address. The practical estimate for planning purposes is that renewal should start 6 to 12 months before expiry.

2. Legal basis

The table below lists the official sources relied upon.

3. Expert insights

Insight 1: Renewal is the first landing point of the ISO 13485 mandate. Under the five-phase roadmap, Phase 2, from 1 June 2025, requires that manufacturers and distributors (importers) applying for renewal provide a valid ISO 13485:2016 certificate issued in the name of the South African licensed establishment, bearing the same address and signed by a SAHPRA-recognised CAB. This means the renewal threshold has been substantively raised for licences expiring after June 2025 — of all the phases, this one applies the most concrete time pressure to established holders. A renewal calendar without a parallel certification calendar will discover the mismatch only months before expiry, when recertification can no longer be completed in time.

Insight 2: The annual retention fee is not waived in a renewal year. SAHPRA states expressly in its fee revision explanation that, because the Medicines Act does not allow an exemption upon renewal, the annual retention fee remains payable in the year of renewal. This is an easily overlooked overlapping expense — when budgeting across the 5-year cycle, companies must calculate the renewal fee plus that year’s annual retention fee together. Treating the renewal payment as settling the year’s obligations in full is precisely the error the fee revision explanation anticipates, and it risks late-payment consequences on the retention side.

Insight 3: Renewal is not an automatic extension; expiry means lapse. The licence is valid for 5 years, and failure to complete renewal before expiry causes the licence to lapse, whereupon manufacture, distribution, import, export or sale is no longer permitted without a valid licence. The time risk of renewal far exceeds its fee risk — companies should start early enough before expiry, particularly given that an ISO 13485 certificate may need to be reissued first. The commercial consequences of a lapsed licence include halted shipments and breaches of supply agreements, which dwarf the renewal fee itself.

Insight 4: Renewal is the consolidated checkpoint for list and premises information. Renewal materials must reflect the current product list, premises, Authorised Representative and QMS status. The practical estimate: treat renewal as a full compliance health check and start the internal reconciliation 6 to 12 months ahead, rather than filling in forms at the last moment. Every discrepancy discovered late — a warehouse not on the licence, an AR whose appointment has lapsed, a catalogue item absent from the list — becomes a separate correction exercise inside a shrinking window.

Insight 5: Renewal fees are tiered by licence type and adjusted annually. The renewal fee standards for manufacturers and for distributors, wholesalers, import and export differ, and the SAHPRA tariff may be adjusted annually. The current tariff must be re-checked before applying, rather than relying on historical amounts. Budget owners should build the annual tariff check into the renewal calendar itself, so that a fee change published mid-year is caught before the renewal payment is made and the application is not returned for insufficient payment.

4. Practical recommendations

The following actions make the 5-year renewal cycle manageable.

1. Maintain a 5-year renewal calendar: start 6 to 12 months before expiry.
2. Check the ISO 13485 certificate status first: it is a hard renewal gate, so plan reissuance or scope extension early.
3. Pay the annual retention fee in the renewal year as well: budgets must add the two together.
4. Use renewal as an occasion for a full compliance reconciliation: product list, premises, AR and QMS.
5. Re-check the current tariff before applying: amounts are adjusted annually.
6. Retain the renewal acknowledgement of receipt: so compliance status can be evidenced across any gap period.

5. Verification checklist

Confirm every item below at the start of the renewal cycle.

• □ The licence expiry date has been registered with a reminder set 6 to 12 months in advance
• □ The renewal basis in Section 22D and Regulation 6 has been confirmed
• □ The ISO 13485 certificate is ready (a hard renewal requirement from 2025-06-01)
• □ The certificate holder name and address match the licence, and the CAB is recognised by SAHPRA
• □ The budget covers the renewal fee plus the annual retention fee for the renewal year
• □ The product list, premises and AR information have been synchronously updated
• □ The current renewal fee standards in the tariff have been re-checked
• □ The renewal acknowledgement has been retained and can cover a possible gap period

Regulatory information verified as of 29 October 2026. The regulations, guidance and effective dates described in this article are limited to the official sources listed in the legal basis section above, as published on that date. Where official documents are subsequently updated, the latest published version prevails.

• South Africa local resources: GRZAN assists manufacturers from the Chinese mainland and overseas with SAHPRA medical device Establishment Licence (MDEL) applications and product registration preparation, including Authorised Representative (AR) scheme design, ISO 13485 certification pathway planning and CAB selection, GMDN coding and classification determination, technical documentation preparation, and the establishment of vigilance and adverse event reporting mechanisms.
• Service capabilities: product attribute determination and risk classification (Class A/B/C/D), establishment licence application and renewal, reliance pathway justification, technical documentation and Essential Principles conformity argumentation, labelling and instructions-for-use localisation (English), and post-market vigilance and annual compliance information submission support.
• Contact: hito.lin@grzan.cn; website www.grzan.cn.